Restenosis treatment

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/11 (2006.01) A61K 31/00 (2006.01) A61K 38/00 (2006.01) A61K 38/21 (2006.01) C12N 9/00 (2006.01) C12Q 1/68 (2006.01)

Patent

CA 2403444

The present invention relates to the use of an inhibitor for the interferon .gamma. signaling pathway for the preparation of a pharmaceutical composition for the treatment or prevention of restenosis. Furthermore, the present invention provides for a method for the identification of an inhibitor of the IFN-.gamma. signaling pathway.

La présente invention concerne l'utilisation d'un inhibiteur pour le passage de signalisation de l'interféron .gamma. en vue de la préparation d'une composition pharmaceutique destinée au traitement ou à la prévention de la resténose. En outre, la présente invention concerne une méthode destinée à l'identification d'un inhibiteur de la voie de signalisation de l'IFN-.gamma..

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Restenosis treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Restenosis treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Restenosis treatment will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2011221

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.